Evidence map›Paper›PMID 41256714›Full record

ArticlebioRxiv : the preprint server for biology2025

Rapid discovery of new-to-nature protein domains by novelty-first forcing of language models.

Arjuna Subramanian, Matt Thomson

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Arjuna SubramanianDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125.ORCID 0009-0004-2790-0209
Matt ThomsonDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125.

Funding

A Global Map of Interactions Among Human Cell Surface Proteins and Secreted LigandsR01GM150125 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI GARCIA, KENAN CHRISTOPHER, THOMSON, MATTHEW W. · 2022 to 2025
$11.3M
NIGMS NIH HHS R01 GM150125
6 · The paper itself

Abstract

Approximations for the existence and extent of physically permissible protein structures beyond those found in nature vary wildly. As predicted structure databases swell thanks to abundant sequence data and generative protein design models concurrently grow in their power to propose new aspects of protein structure, these questions and those of which essential features (e.g. stability, function, robustness) distinguish natural domains from novel ones have been cast in even sharper relief. We demonstrate that protein language models (PLMs) can simultaneously innovate in sequence and structure to suggest new-to-nature protein domains displaying supersecondary and tertiary elements outside of categorized CATH superfamilies. Developing and applying two orthogonal processes for obtaining compact and globular folds from PLMs without bias from other physicochemical or functional constraints, we discover putative novel domains that emerge parallel to known natural ones at rates far exceeding those obtainable by bioinformatic mining of structure databases. Computational characterization of these domain candidates indicates that many exhibit reasonable folding thermodynamics and kinetics, suggesting that natural protein structure-space is far from biophysically complete. These results point away from stability as the definitive selective force behind the observed landscape of real protein folds, and insinuate that many unrealized folds may be equally consistent with the structural rules of protein-based life.

Identifiers

PMID41256714
PMCPMC12622050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.